Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Decitabine

Review the clinical trials studying decitabine on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 26-34 of 34

8-Chloroadenosine in Combination with Decitabine and Venetoclax for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Avapritinib in Combination with Decitabine for the Treatment of Patients with Systemic Mastocytosis with an Associated Hematologic Neoplasm
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Lisaftoclax, Olverembatinib, and Decitabine for the Treatment of Patients with Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Azacitidine and Decitabine for the Treatment of Myelodysplastic Syndrome or Other Related Cancers
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
Status: Active
Location: See ClinicalTrials.gov
Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
Status: Active
Location: See ClinicalTrials.gov
Decitabine in Combination with Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
Status: Approved
Location: Mayo Clinic in Florida, Jacksonville, Florida
Palbociclib and Sorafenib, Decitabine, Dexamethasone or Venetoclax in Treating Patients with Recurrent or Refractory Leukemia
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Patients with Blood Cancers
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas